Skip to content

AACR vs ASH for Exhibitors

Side-by-side data and our editorial take on which conference is the right exhibit investment for your medical device.

By Buzzbox Media · Last reviewed August 3, 2026

If you exhibit medical devices, AACR and ASH are likely both on your shortlist. Both serve overlapping clinical buyers, but the audience composition, booth economics, and exhibit floor experience differ in ways that materially affect ROI. AACR draws 23,000 attendees with no booth pricing published by the organizer. ASH draws 26,000 attendees with no booth pricing published by the organizer. Below is the side-by-side data plus our editorial take on which conference fits which kind of exhibitor.

AACR Buzzbox Score 9.1 ASH Buzzbox Score 9.6
Event details
Dates April 17-22, 2026December 12-15, 2026
Location San Diego Convention Center, San Diego, CAErnest N. Morial Convention Center, New Orleans, LA
Audience
Attendees 23,00026,000
Exhibitors 600275
Purchasing authority, Buzzbox Media estimate ~20%~35%
Effective buyers, Buzzbox Media estimate 4,6009,100
Costs
$/sqft n/a$120
10×10 space n/a$12,000
All‑in, Buzzbox Media estimate n/an/a
Cost per buyer, Buzzbox Media estimate n/an/a

Why exhibit at AACR

The world's largest cancer research conference: 23,000 attendees, 600 exhibitors, 141 countries. If you make diagnostic instruments, genomics/sequencing platforms, liquid biopsy tests, or research reagents, AACR is where the global cancer research community sees your technology. The 6-day format gives more time for meaningful booth conversations than typical 3-day shows.

Why exhibit at ASH

The world's largest hematology meeting: 26,000 attendees from 110+ countries. Late-breaking clinical trial data makes this the single most important event for hematology drug and diagnostic launches. If you sell flow cytometers, coagulation analyzers, cell/gene therapy products, or molecular diagnostics for blood disorders, ASH is the anchor show of your annual conference calendar.

Why skip AACR

AACR is a research conference, not a clinical buying show. Purchasing authority is low (~20%, Buzzbox Media estimate) because the audience is predominantly academic researchers and scientists, not practicing oncologists with capital budgets. If you need same-quarter device sales, ASCO or ASH is a better fit. The exhibit floor also competes with 730 speaker sessions for attendee attention.

Why skip ASH

Booth pricing is opaque and expensive (pharma dominates with massive booths). The audience is heavily academic and research-oriented, so pure diagnostic device companies may find more actionable buyers at CAP (pathology) or AABB (blood banking). December in New Orleans also means holiday scheduling conflicts for booth staff and potential weather disruptions.

AACR publishes no booth pricing we can link to, so no cost is listed for it. See the official AACR site for exhibitor details. ASH booth figures are estimates read from its published exhibitor prospectus, not quotes. Confirm current pricing with each organizer before committing a budget.

Frequently Asked Questions

Does AACR or ASH have more decision makers?

ASH does, on a Buzzbox Media estimate: roughly 9,100 effective buyers against about 4,600 at AACR. Effective buyers multiplies total attendance by the share of attendees who hold purchasing authority, so ASH works out to about 26,000 attendees at roughly 35% authority, and AACR to about 23,000 at roughly 20%. Both inputs are estimates drawn from organizer reporting and our own exhibitor research, so read the gap as directional rather than exact.

Want to add a third conference to this comparison?

Compare these conferences in our interactive tool

Other conferences you might consider

Buzzbox Media is a medical device advertising agency with over 15 years in medtech. See our conference marketing.

Exhibiting at a medical conference? See what Buzzbox Media built for the AAGL Global Congress, which won four 2025 Association TRENDY Awards.